• 281 Citations
  • 9 h-Index
20112019
If you made any changes in Pure these will be visible here soon.

Research Output 2011 2019

  • 281 Citations
  • 9 h-Index
  • 21 Article
  • 3 Review article
  • 1 Editorial
Filter
Article
2018
1 Citation (Scopus)

Self-evaluation of duration of adjuvant chemotherapy side effects in breast cancer patients: A prospective study

Galizia, D., Milani, A., Geuna, E., Martinello, R., Cagnazzo, C., Foresto, M., Longo, V., Berchialla, P., Solinas, G., Calori, A., Grasso, B., Volpone, C., Bertola, G., Parola, G., Tealdi, G., Giuliano, P. L., Ballari, A. M., Aglietta, M. & Montemurro, F., Sep 1 2018, In : Cancer Medicine. 7, 9, p. 4339-4344 6 p.

Research output: Contribution to journalArticle

Diagnostic Self Evaluation
Adjuvant Chemotherapy
Prospective Studies
Breast Neoplasms
Terminology

What is the best pharmacotherapeutic strategy for HER-2 positive breast cancer?

Giannone, G., Milani, A., Geuna, E., Galizia, D., Biello, F. & Montemurro, F., Nov 6 2018, In : Expert Opinion on Pharmacotherapy. p. 1-5 5 p.

Research output: Contribution to journalArticle

2017
22 Citations (Scopus)

A first-in-human, Phase I, dose-escalation study of TAK-117, A selective PI3Ka isoform inhibitor, in patients with advanced solid malignancies

Juric, D., De Bono, J. S., LoRusso, P. M., Nemunaitis, J., Heath, E. I., Kwak, E. L., Mercade, T. M., Geuna, E., De Miguel-Luken, M. J., Patel, C., Kuida, K., Sankoh, S., Westin, E. H., Zohren, F., Shou, Y. & Tabernero, J., Sep 1 2017, In : Clinical Cancer Research. 23, 17, p. 5015-5023 9 p.

Research output: Contribution to journalArticle

Protein Isoforms
Neoplasms
Safety
Aspartate Aminotransferases
Alanine Transaminase
Cerebrospinal Fluid
Breast Neoplasms
Neoplasm Metastasis
DNA
Brain
2016
3 Citations (Scopus)

Investigational ErbB-2 tyrosine kinase inhibitors for the treatment of breast cancer

Martinello, R., Milani, A., Geuna, E., Zucchini, G., Aversa, C., Nuzzo, A. & Montemurro, F., Apr 2 2016, In : Expert Opinion on Investigational Drugs. 25, 4, p. 393-403 11 p.

Research output: Contribution to journalArticle

TYK2 Kinase
Breast Neoplasms
Investigational Drugs
Neoplasms
Gene Amplification
2015

Adjuvant ovarian suppression in premenopausal breast cancer

Montemurro, F., Perrone, F. & Geuna, E., Apr 23 2015, In : New England Journal of Medicine. 372, 17, p. 1672-1673 2 p.

Research output: Contribution to journalArticle

Adjuvant ovarian suppression in premenopausal breast cancer

Montemurro, F., Perrone, F. & Geuna, E., Apr 23 2015, In : New England Journal of Medicine. 372, 17, p. 1672-1673 2 p.

Research output: Contribution to journalArticle

25 Citations (Scopus)

Buparlisib, an oral pan-PI3K inhibitor for the treatment of breast cancer

Geuna, E., Milani, A., Martinello, R., Aversa, C., Valabrega, G., Scaltriti, M. & Montemurro, F., 2015, In : Expert Opinion on Investigational Drugs. 24, 3, p. 421-431 11 p.

Research output: Contribution to journalArticle

Phosphatidylinositol 3-Kinase
Breast Neoplasms
Sirolimus
Class I Phosphatidylinositol 3-Kinases
Therapeutics
7 Citations (Scopus)

Clinical utility of exemestane in the treatment of breast cancer

Zucchini, G., Geuna, E., Milani, A., Aversa, C., Martinello, R. & Montemurro, F., May 27 2015, In : International Journal of Women's Health. 7, p. 551-563 13 p.

Research output: Contribution to journalArticle

exemestane
Breast Neoplasms
Aromatase Inhibitors
Therapeutics
Estrogen Receptor Modulators
15 Citations (Scopus)

Complications of hyperglycaemia with PI3K-AKT-mTOR inhibitors in patients with advanced solid tumours on Phase I clinical trials

Geuna, E., Roda, D., Rafii, S., Jimenez, B., Capelan, M., Rihawi, K., Montemurro, F., Yap, T. A., Kaye, S. B., De Bono, J. S., Molife, L. R. & Banerji, U., Dec 1 2015, In : British Journal of Cancer. 113, 11, p. 1541-1547 7 p.

Research output: Contribution to journalArticle

Clinical Trials, Phase I
Phosphatidylinositol 3-Kinases
Hyperglycemia
Neoplasms
Incidence
22 Citations (Scopus)

Higher risk of infections with PI3K-AKT-mTOR pathway inhibitors in patients with advanced solid tumors on phase I clinical trials

Rafii, S., Roda, D., Geuna, E., Jimenez, B., Rihawi, K., Capelan, M., Yap, T. A., Molife, L. R., Kaye, S. B., De Bono, J. S. & Banerji, U., Apr 15 2015, In : Clinical Cancer Research. 21, 8, p. 1869-1876 8 p.

Research output: Contribution to journalArticle

Clinical Trials, Phase I
Phosphatidylinositol 3-Kinases
Infection
Neoplasms
Confidence Intervals
7 Citations (Scopus)

Linifanib: Current status and future potential in cancer therapy

Aversa, C., Leone, F., Zucchini, G., Serini, G., Geuna, E., Milani, A., Valdembri, D., Martinello, R. & Montemurro, F., Jun 1 2015, In : Expert Review of Anticancer Therapy. 15, 6, p. 677-687 11 p.

Research output: Contribution to journalArticle

N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N1-(2-fluoro-5-methylphenyl)urea
Neoplasms
Clinical Trials
Therapeutics
Angiogenesis Inducing Agents
39 Citations (Scopus)

The neutrophil-lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials

Kumar, R., Geuna, E., Michalarea, V., Guardascione, M., Naumann, U., Lorente, D., Kaye, S. B. & De Bono, J. S., Mar 31 2015, In : British Journal of Cancer. 112, 7, p. 1157-1165 9 p.

Research output: Contribution to journalArticle

Neutrophils
Clinical Trials
Lymphocytes
Neoplasms
Clinical Trials, Phase I
2014

FDG avidity at PET/CT during adjuvant hormonal therapy in patients with breast cancer

Evangelista, L., Redana, S., Racca, M., Geuna, E., Vinante, L., Zago, G., De Carolis, V., Ghiotto, C., Saladini, G. & Varetto, T., Feb 2014, In : Clinical Nuclear Medicine. 39, 2

Research output: Contribution to journalArticle

Breast Neoplasms
Chi-Square Distribution
Tumor Biomarkers
Hormones
Students
35 Citations (Scopus)

Metastatic breast cancer subtypes and central nervous system metastases

Aversa, C., Rossi, V., Geuna, E., Martinello, R., Milani, A., Redana, S., Valabrega, G., Aglietta, M. & Montemurro, F., Oct 1 2014, In : Breast. 23, 5, p. 623-628 6 p.

Research output: Contribution to journalArticle

Central Nervous System
Breast Neoplasms
Neoplasm Metastasis
Neoplasms
Survival
53 Citations (Scopus)

Overcoming endocrine resistance in metastatic breast cancer: Current evidence and future directions

Milani, A., Geuna, E., Mittica, G. & Valabrega, G., Dec 10 2014, In : World Journal of Clinical Oncology. 5, 5, p. 990-1001 12 p.

Research output: Contribution to journalArticle

Breast Neoplasms
exemestane
letrozole
Estrogen Receptors
Aromatase Inhibitors
2012
9 Citations (Scopus)
Hormones
Breast Neoplasms
Therapeutics
Medical Oncology
Expert Testimony
16 Citations (Scopus)
Breast Neoplasms
Protein-Tyrosine Kinases
Therapeutics
Clinical Trials, Phase I
Cytoprotection
2011
7 Citations (Scopus)

Hitting multiple targets in HER2-positive breast cancer: Proof of principle or therapeutic opportunity?

Geuna, E., Milani, A., Redana, S., Rossi, V., Valabrega, G., Aglietta, M. & Montemurro, F., Mar 2011, In : Expert Opinion on Pharmacotherapy. 12, 4, p. 549-565 17 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Therapeutics
Expert Testimony
Biological Factors
Receptor Protein-Tyrosine Kinases
1 Citation (Scopus)

Trastuzumab beyond progression in retrospective analyses: An issue of equal opportunities

Montemurro, F., Redana, S., Geuna, E., Milani, A., Rossi, V., Martinello, R., Valabrega, G. & Aglietta, M., 2011, In : The oncologist. 16, 4, p. 534-536 3 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Trastuzumab in the adjuvant setting: A practical review

Rossi, V., Redana, S., Milani, A., Geuna, E., Valabrega, G., Aglietta, M. & Montemurro, F., Mar 2011, In : Therapy. 8, 2, p. 161-177 17 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Drug Therapy
Trastuzumab
Anthracyclines
Adjuvant Chemotherapy